分岐病変の市場レポート：タイプ、用途、地域別、2024～2032年

世界の分岐病変の市場規模は2023年に24億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけての成長率（CAGR）は4.6％を示し、2032年には37億米ドルに達すると予測しています。

分岐部病変は、重要な側枝（SB）の起始部に隣接する冠動脈の狭窄を指します。乱れた血流と高い剪断応力のために動脈硬化性プラークが発生しやすいです。解析、手技時間、X線照射、長期経過観察などの技術を用いて治療されます。さらに、三次元（3D）血管造影やマルチスライスCTが分岐角の測定に利用されています。機器，画像診断，補助薬剤療法，バスキュラーアクセスの進歩により，複雑な分岐部病変の管理は世界的に可能になってきています。

分岐病変の市場動向

冠動脈疾患（CAD）の増加が分岐部病変の発症リスクを高めています。これは市場の成長を後押しする重要な要因の一つです。このほか、革新的なデバイスの承認、保険適用範囲の拡大、画像診断モダリティの向上なども市場の成長を強化しています。さらに、医療上の病気を発症しやすい高齢者人口が増加していることや、償還のために各国政府が行っている支援策が市場成長を支えています。医療ツーリズムの増加、低侵襲（MI）手技に対する需要の高まり、医療インフラの改善なども、市場成長に寄与する要因のひとつです。これとは別に、新しい治療技術に関する研究が進んでいることも市場を牽引しています。例えば、SB閉塞の危険性が高い、あるいは致命的な結果をもたらす複雑な分岐部病変に対するSzabo 2ステント法の有効性を研究しています。さらに、ステントやバルーンに関する広範な臨床試験と熟練した医療専門家の増加が相まって、分岐部病変の治療に伴うリスクが減少し、市場にプラスの影響を与えると予想されます。

本レポートで扱う主要質問

• 2023年の世界の分岐病変の市場の市場規模は？
• 2024～2032年の世界の分岐病変の市場の予想成長率は？
• 世界の分岐病変の市場に対するCOVID-19の影響は？
• 世界の分岐病変の市場を牽引する主要因は何か？
• 世界の分岐病変の市場の用途別内訳は？
• 分岐病変の市場の世界における主要地域は？
• 分岐病変の市場の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の分岐病変市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 1ステント
• 2ステント

第7章 市場内訳：用途別

• 冠動脈血管
• 末梢血管

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Boston Scientific Corporation
  • Cardinal Health
  • Medtronic plc
  • Spectranetics（Koninklijke Philips N.V.）
  • Terumo Corporation

List of Figures

• Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
• Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2023
• Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2023
• Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2023
• Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2023
• Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
• Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
• Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million US$), 2024-2032
• Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 5: Global: Bifurcation Lesions Market: Competitive Structure
• Table 6: Global: Bifurcation Lesions Market: Key Players

The global bifurcation lesions market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on types and application.

Breakup by Types:

One-Stent

Two-Stent

Breakup by Application:

Coronary Vascular

Peripheral Vascular

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

• 1. What was the size of the global bifurcation lesions market in 2023?
• 2. What is the expected growth rate of the global bifurcation lesions market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global bifurcation lesions market?
• 4. What are the key factors driving the global bifurcation lesions market?
• 5. What is the breakup of the global bifurcation lesions market based on the application?
• 6. What are the key regions in the global bifurcation lesions market?
• 7. Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Types

• 6.1 One-Stent
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Two-Stent
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Coronary Vascular
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Peripheral Vascular
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Boston Scientific Corporation
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Cardinal Health
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Medtronic plc
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Terumo Corporation
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis